ArticleInternational journal of cardiology. Heart & vasculature2025
Overexpression of Neural Precursor Cell Expressed Developmentally Downregulated 9 (NEDD9) reduces ox-LDL-induced Anoikis in atherosclerotic vascular endothelial cells.
Article in International journal of cardiology. Heart & vasculature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retracted
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study purposes to explore the action of the Anoikis gene in vascular endothelial cell injury, explore diagnostic biomarkers, and provide new insights into potential molecular mechanisms, as well as offer a new perspective for disease detection and treatment. Methods: The Anoikis gene set was used for enrichment analysis on the Gene Expression Omnibus (GEO: GSE100927) dataset, to identify the intersection genes related to Atherosclerosis. Further, the expression and pathway enrichment of Anoikis genes in GSE100927 was investigated. The Least Absolute Shrinkage and Selection Operator (LASSO) method for dimensionality reduction modeling was employed to obtain Atherosclerosis-related genes and construct Anoikis score. The NEDD9, FOSB, and ERCC1 expression in ox-LDL-induced the Bend.3 cells was validated by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Overexpression or silencing NEDD9 on Anoikis in ox-LDL and detachment-induced the Bend.3 cells was analyzed by using Cell Counting Kit-8 (CCK8), 5-Ethynyl-2'-deoxyuridine (EdU), and flow cytometry assays. Results: Based on Anoikis gene analysis, NFIL3, NR4A3, ADAMTS4, NEDD9, STX17-AS1, and CSF3 were found to be under-expressed, while FOSB and ERCC1 were found to be over-expressed in the atherosclerosis group compared to the normal group. LASSO regression analysis yielded an Anoikis score = -9.522 Conclusion: This study developed a reliable atherosclerotic Anoikis model for predicting endothelial cell injury. During Anoikis genes, the overexpression of NEDD9 reduces ox-LDL and detachment-induced endothelial cell Anoikis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.